Loading company details...
Beta
Latest Form 4 (Jul 31, 2026): Pharis Mohideen (Chief Medical Officer): Sale of 464 shares, $1.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Pharis Mohideen, Chief Medical Officer | Sale | 464 | $1.3K |
| Feb 2, 2026 | Pharis Mohideen, Chief Medical Officer | Sale | 534 | $2.6K |
| Jan 14, 2026 | BAKER BROS. ADVISORS LP | Exercise/Conversion | 2,299,656 | n/a |
| Dec 19, 2025 | Bpifrance Epic | Sale | 2,036,990 | $9.86M |
| Nov 25, 2025 | Pharis Mohideen, Chief Medical Officer | Sale | 6,496 | $18.7K |
| Nov 25, 2025 | Virginie Boucinha, Chief Financial Officer | Grant/Award | 32,000 | n/a |
| Nov 25, 2025 | Kevin Michael Trapp, Chief Commercial Officer | Grant/Award | 55,000 | n/a |
| Nov 25, 2025 | Daniel Tasse, CHIEF EXECUTIVE OFFICER | Grant/Award | 964,000 | n/a |
| Jul 31, 2025 | Pharis Mohideen, Chief Medical Officer | Sale | 464 | $1.0K |
| May 27, 2025 | Pharis Mohideen, Chief Medical Officer | Sale | 397 | $730.48 |